IL6R and nasopharyngeal carcinoma: IL-6R expression may confer a selective advantage to EBV-infected NPE cells in vivo because of their enhanced response to IL-6-induced STAT3 activation, and therefore cells with higher IL-6R expression are favorably selected EBV-infected NPC cells.